Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies

Clin Exp Immunol. 1999 Oct;118 Suppl 1(Suppl 1):29-34. doi: 10.1046/j.1365-2249.1999.00000.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Blood / microbiology
  • Blood / virology
  • Blood Specimen Collection
  • Blood-Borne Pathogens
  • Consumer Product Safety
  • Creutzfeldt-Jakob Syndrome / blood
  • Creutzfeldt-Jakob Syndrome / prevention & control
  • Creutzfeldt-Jakob Syndrome / transmission
  • Guidelines as Topic
  • Humans
  • Immunization, Passive* / adverse effects
  • Immunoglobulins* / isolation & purification
  • Immunologic Deficiency Syndromes / therapy
  • Virus Diseases / blood
  • Virus Diseases / prevention & control
  • Virus Diseases / transmission

Substances

  • Immunoglobulins